Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

CALCIO - Serie B - AC Reggiana vs Modena FC

Generic image of a Serie B soccer ball during the Serie B match between Modena FC and Reggiana Calcio at Mapei Stadium Reggio Emilia on 28 October, 2025 in Modena, Italy.

E

CALCIO - Serie B - Modena FC vs US Avellino

Generic image of the referee spraying foam from a spray can to mark the barrier line during the Serie B match between Modena FC and Avellino at Stadio Alberto Braglia Modena on 31 August, 2025 in Modena, Italy.

E

CALCIO - Serie B - Modena FC vs US Avellino

Generic image of soccer ball kicking during the Serie B match between Modena FC and Avellino at Stadio Alberto Braglia Modena on 31 August, 2025 in Modena, Italy.

E

CALCIO - Serie A Femminile - Serie A Women's Cup - Parma Calcio vs Juventus FC

Generic image of kicking a ball during a head-to-head collision the Serie A Women's Cup match etween Parma Women and Juventus Women at Stadio Ennio Tardini Parma on 22 August, 2025 in Parma, Italy.?

E

CALCIO - Serie A Femminile - Serie A Women's Cup - Parma Calcio vs Juventus FC

Generic image of kicking a ball

E

Illustration - 93% of French Pharmacies to Close on August 16 - France

92% of French pharmacies plan to close on Saturday, August 16, according to the Union of Pharmacists' Unions (USPO). The main reason is the reduction in discounts that manufacturers can grant pharmacists on generic drugs. August, 14, 2025. France, Ile-de-France. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Illustration - 93% of French Pharmacies to Close on August 16 - France

92% of French pharmacies plan to close on Saturday, August 16, according to the Union of Pharmacists' Unions (USPO). The main reason is the reduction in discounts that manufacturers can grant pharmacists on generic drugs. August, 14, 2025. France, Ile-de-France. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Illustration - 93% of French Pharmacies to Close on August 16 - France

92% of French pharmacies plan to close on Saturday, August 16, according to the Union of Pharmacists' Unions (USPO). The main reason is the reduction in discounts that manufacturers can grant pharmacists on generic drugs. August, 14, 2025. France, Ile-de-France. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Illustration - 93% of French Pharmacies to Close on August 16 - France

92% of French pharmacies plan to close on Saturday, August 16, according to the Union of Pharmacists' Unions (USPO). The main reason is the reduction in discounts that manufacturers can grant pharmacists on generic drugs. August, 14, 2025. France, Ile-de-France. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Illustration - 93% of French Pharmacies to Close on August 16 - France

92% of French pharmacies plan to close on Saturday, August 16, according to the Union of Pharmacists' Unions (USPO). The main reason is the reduction in discounts that manufacturers can grant pharmacists on generic drugs. August, 14, 2025. France, Ile-de-France. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Illustration - 93% of French Pharmacies to Close on August 16 - France

92% of French pharmacies plan to close on Saturday, August 16, according to the Union of Pharmacists' Unions (USPO). The main reason is the reduction in discounts that manufacturers can grant pharmacists on generic drugs. August, 14, 2025. France, Ile-de-France. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Illustration - 93% of French Pharmacies to Close on August 16 - France

92% of French pharmacies plan to close on Saturday, August 16, according to the Union of Pharmacists' Unions (USPO). The main reason is the reduction in discounts that manufacturers can grant pharmacists on generic drugs. August, 14, 2025. France, Ile-de-France. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Illustration - 93% of French Pharmacies to Close on August 16 - France

92% of French pharmacies plan to close on Saturday, August 16, according to the Union of Pharmacists' Unions (USPO). The main reason is the reduction in discounts that manufacturers can grant pharmacists on generic drugs. August, 14, 2025. France, Ile-de-France. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Illustration - 93% of French Pharmacies to Close on August 16 - France

92% of French pharmacies plan to close on Saturday, August 16, according to the Union of Pharmacists' Unions (USPO). The main reason is the reduction in discounts that manufacturers can grant pharmacists on generic drugs. August, 14, 2025. France, Ile-de-France. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Illustration - 93% of French Pharmacies to Close on August 16 - France

92% of French pharmacies plan to close on Saturday, August 16, according to the Union of Pharmacists' Unions (USPO). The main reason is the reduction in discounts that manufacturers can grant pharmacists on generic drugs. August, 14, 2025. France, Ile-de-France. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Illustration - 93% of French Pharmacies to Close on August 16 - France

92% of French pharmacies plan to close on Saturday, August 16, according to the Union of Pharmacists' Unions (USPO). The main reason is the reduction in discounts that manufacturers can grant pharmacists on generic drugs. August, 14, 2025. France, Ile-de-France. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

President Claudia Sheinbaum Holds Briefing - Mexico

Alejandro Svarch Pérez, Director General of IMSS-Bienestar, speaks during a news conference, about how the government works to guarantee access to medicines, mainly generic medicines, which lead to a reduction in the price of patented medicines at the National Palace. on July 4, 2025 in Mexico City, Mexico. (Photo by Carlos Santiago/Eyepix Group/ABACAPRESS.COM)

E

President Claudia Sheinbaum Holds Briefing - Mexico

Alejandro Svarch Pérez, Director General of IMSS-Bienestar, speaks during a news conference, about how the government works to guarantee access to medicines, mainly generic medicines, which lead to a reduction in the price of patented medicines at the National Palace. on July 4, 2025 in Mexico City, Mexico. (Photo by Carlos Santiago/Eyepix Group/ABACAPRESS.COM)

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Government Demands Guarantees For Doliprane Production In France

Illustrations Doliprane on October 15, 2024. The French laboratory Sanofi announced on October 4 that it wanted to sell part of its subsidiary Opella, which produces generic drugs such as Doliprane, to an American fund, the American investment fund CD-R. On Wednesday, the French Health Minister called for guarantees that Doliprane would be “produced in France”, that pharmacies would receive “normal supplies” and that “sufficient stocks” would be available. Photo by Jean Pierre Nguyen Van Hai Barbier/ABACAPRESS.COM

E

Illustration - Biogaran

A box of generic ibuprofen from Biogaran laboratories in Marseille, France on April 9, 2024. Photo by Laurent Coust/ABACAPRESS.COM

E

Illustration - Biogaran

A box of generic ibuprofen from Biogaran laboratories in Marseille, France on April 9, 2024. Photo by Laurent Coust/ABACAPRESS.COM

E

Illustration - Biogaran

A box of prednisolone, generic medecine of Solupred, from Biogaran laboratories in Marseille, France on April 9, 2024. Photo by Laurent Coust/ABACAPRESS.COM

E

Illustration - Biogaran

A box of generic ibuprofen from Biogaran laboratories in Marseille, France on April 9, 2024. Photo by Laurent Coust/ABACAPRESS.COM

E

Illustration - Biogaran

A box of prednisolone, generic medecine of Solupred, from Biogaran laboratories in Marseille, France on April 9, 2024. Photo by Laurent Coust/ABACAPRESS.COM

E

Illustration - Biogaran

A box of generic ibuprofen from Biogaran laboratories in Marseille, France on April 9, 2024. Photo by Laurent Coust/ABACAPRESS.COM

E

Illustration - Biogaran

A box of generic ibuprofen from Biogaran laboratories in Marseille, France on April 9, 2024. Photo by Laurent Coust/ABACAPRESS.COM

E

Drugmaker Kowa, Israel's Teva plan joint generic drug firm

TOKYO, Japan - Shlomo Yanai (L), president and chief executive officer of Israel's Teva Pharmaceutical Industries Ltd., and Yoshihiro Miwa, president of Japanese drugmaker Kowa Co., shake hands during a press conference in Tokyo on Sept. 24 at which they announced the two companies will set up a joint generic drug company in Tokyo next year.

E

TOP14 - Stade Francais Paris vs Pau

Generic view of a Stade FrancisâÂÂs rugby ball during the rugby TOP 14 match between Stade Français Paris (SFP) and Section Paloise (SP) at the Jean Bouin Stadium, in Paris, France on April 24, 2021. Photo by Julien Poupart/ABACAPRESS.COM

E

Thuret Garden - Antibes

The Jardin botanique de la Villa Thuret, Thuret Garden is a renowned botanical garden located on the grounds of the Villa Thuret, 90, chemin Raymond, Antibes Juan-les-Pins, Alpes-Maritimes, Provence-Alpes-Côte d'Azur, France. Created in 1857, by Gustave Thuret (1810-1875) and managed by INRAE ââsince 1964, the Villa Thuret, owned by the State, is a scientific laboratory and a botanical garden-arboretum for the introduction and acclimatization of exotic plant species. The site is managed by the UEVT (Villa Thuret Experimental Unit), itself attached to the EFPA (Ecology of Forests, Grasslands and Aquatic Environments Department of INRA). The scientific mission of the unit relates to the introduction of plants from the Mediterranean climate and their cultivation to ensure their phenotyping; this mission is designated by the generic term of acclimatization. (Credit:Fourmy Mario/ABACA/Kyodo News Images)

E

Thuret Garden - Antibes

The Jardin botanique de la Villa Thuret, Thuret Garden is a renowned botanical garden located on the grounds of the Villa Thuret, 90, chemin Raymond, Antibes Juan-les-Pins, Alpes-Maritimes, Provence-Alpes-Côte d'Azur, France. Created in 1857, by Gustave Thuret (1810-1875) and managed by INRAE ââsince 1964, the Villa Thuret, owned by the State, is a scientific laboratory and a botanical garden-arboretum for the introduction and acclimatization of exotic plant species. The site is managed by the UEVT (Villa Thuret Experimental Unit), itself attached to the EFPA (Ecology of Forests, Grasslands and Aquatic Environments Department of INRA). The scientific mission of the unit relates to the introduction of plants from the Mediterranean climate and their cultivation to ensure their phenotyping; this mission is designated by the generic term of acclimatization. (Credit:Fourmy Mario/ABACA/Kyodo News Images)

E

TOP14 - Stade Francais Paris vs ASM Clermont

Generic view of a ruby referee during the rugby TOP 14 match between Stade Français Paris (SFP) and ASM Clermont (ASM) at the Jean Bouin Stadium, in Paris, France on March 27, 2021. Photo by Julien Poupart/ABACAPRESS.COM (Credit:Poupart Julien/ABACA/Kyodo News Images)

E

Womens Football Friendly - France v USA

Generic view of the usaâÂÂs sockets during the international friendly women's football match France v USA at the Oceane Stadium in Le Havre, France, April 13, 2021. Photo by Julien Poupart/ABACAPRESS.COM (Credit:Poupart Julien/ABACA/Kyodo News Images)

E

Champions Cup - Racing 92 vs Edinburgh Rugby

Generic view of a Champions Cup flag during the 8th Finale match of Champions Cup between Racing 92 (R92) and Edinburgh Rugby (ER) at the Paris La Defense Arena, in Nanterre, France on April 4, 2021. Photo by Julien Poupart/ABACAPRESS.COM (Credit:Poupart Julien/ABACA/Kyodo News Images)

E

Drugmaker Kowa, Israel's Teva plan joint generic drug firm

TOKYO, Japan - Shlomo Yanai (L), president and chief executive officer of Israel's Teva Pharmaceutical Industries Ltd., and Yoshihiro Miwa, president of Japanese drugmaker Kowa Co., shake hands during a press conference in Tokyo on Sept. 24 at which they announced the two companies will set up a joint generic drug company in Tokyo next year. (Kyodo)

E

GENERIC PRODUCTION SHOT

E

Japan generic drug maker Nichi-Iko to acquire Sagent of U.S.

Yuichi Tamura, president of generic drug company Nichi-Iko Pharmaceutical Co., has a press conference in Toyama, Japan, on July 11, 2016. Nichi-Iko will acquire U.S. generic drug maker Sagent Pharmaceuticals Inc. for roughly $736 million in a bid to expand its presence in the U.S. market. (Kyodo) ==Kyodo

E

Sawai Pharmaceutical chief eyes hefty increase in generic output

Mitsuo Sawai, president of major Japanese generic drug maker Sawai Pharmaceutical Co., speaks to Kyodo News in Osaka, western Japan, on Sept. 18, 2015, about a plan to sharply expand its capacity to produce generic drugs. (Kyodo) ==Kyodo

E

Sawai Pharmaceutical chief eyes hefty increase in generic output

Mitsuo Sawai, president of major Japanese generic drug maker Sawai Pharmaceutical Co., speaks to Kyodo News in Osaka, western Japan, on Sept. 18, 2015, about a plan to sharply expand its capacity to produce generic drugs. (Kyodo) ==Kyodo

E

Zentiva, company, medicine, drugs, tablets, medicines, Ibalgin, ibuprofen

Manufacturing facility of Zentiva pharmaceutical company, Prague, Czech Republic on Monday, Mar. 23, 2009. Zentiva, an international pharmaceutical company focused on selling, manufacturing and developing generic pharmaceutical products, employs more then 6000 people in Czech Republic, Slovakia, Romania and Turkey. (CTK Photo/Martin Sterba)